The Need for Biosimilars in Inflammatory Diseases and Regulatory Requirements for Approval
March 29th 2024Drs Lio, Botsoglou, and Axelrad discuss the need for biosimilars in inflammatory diseases, and clinical pharmacist Dr Humphreys reviews the regulatory requirements for biosimilars to receive FDA approval.
Read More